List of works - Segev Barak

AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents

scientific article published on 22 December 2010

Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice

scientific article published on 27 June 2018

Chromatin remodeling — a novel strategy to control excessive alcohol drinking ⬇️

scientific article published on February 19, 2013

Counterconditioning During Reconsolidation Prevents Relapse of Cocaine Memories

scientific article published on 29 July 2016

Counterconditioning following memory retrieval diminishes reinstatement of appetitive memories in humans:

Disruption of relapse to alcohol seeking by aversive counterconditioning following memory retrieval

scientific article published on 13 July 2020

Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine.

scientific article published on 24 February 2010

Fibroblast Growth Factor 2 in the Dorsomedial Striatum Is a Novel Positive Regulator of Alcohol Consumption.

scientific article published on 8 August 2017

Flood-conditioned place aversion as a novel non-pharmacological aversive learning procedure in mice.

scientific article published on 8 May 2018

GDNF and alcohol use disorder.

scientific article

GDNF is a novel ethanol-responsive gene in the VTA: implications for the development and persistence of excessive drinking.

scientific article published on 9 January 2013

Glial cell line-derived neurotrophic factor (GDNF) is an endogenous protector in the mesolimbic system against excessive alcohol consumption and relapse.

scientific article published on 6 May 2014

Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seeking

scientific article

Growth Factors and Alcohol Use Disorder

scientific article published on 21 January 2020

Inhibition of FGF Receptor-1 Suppresses Alcohol Consumption: Role of PI3 Kinase Signaling in Dorsomedial Striatum

scientific article published on 02 August 2019

Lyn kinase regulates mesolimbic dopamine release: implication for alcohol reward

scientific article published on February 2011

Memory erasure, enhanced extinction and disrupted reconsolidation.

scientific article published in February 2012

Positive autoregulation of GDNF levels in the ventral tegmental area mediates long-lasting inhibition of excessive alcohol consumption ⬇️

scientific article published on January 1, 2011

Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia.

scientific article

Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat.

scientific article published on 16 August 2008

Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target

scientific article published on 21 March 2011

Re-exposure to nicotine-associated context from adolescence enhances alcohol intake in adulthood.

scientific article

Recent Advances in the Discovery and Preclinical Testing of Novel Compounds for the Prevention and/or Treatment of Alcohol Use Disorders ⬇️

scientific article published on June 4, 2012

Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.

scientific article

The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia.

scientific article published on 7 January 2011

The role of fibroblast growth factor 2 in drug addiction

scientific article published on 12 September 2018

List of works by Segev Barak

AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents

Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice

Chromatin remodeling — a novel strategy to control excessive alcohol drinking ⬇️

Counterconditioning During Reconsolidation Prevents Relapse of Cocaine Memories

Counterconditioning following memory retrieval diminishes reinstatement of appetitive memories in humans:

Disruption of relapse to alcohol seeking by aversive counterconditioning following memory retrieval

Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine.

Fibroblast Growth Factor 2 in the Dorsomedial Striatum Is a Novel Positive Regulator of Alcohol Consumption.

Flood-conditioned place aversion as a novel non-pharmacological aversive learning procedure in mice.

GDNF and alcohol use disorder.

GDNF is a novel ethanol-responsive gene in the VTA: implications for the development and persistence of excessive drinking.

Glial cell line-derived neurotrophic factor (GDNF) is an endogenous protector in the mesolimbic system against excessive alcohol consumption and relapse.

Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seeking

Growth Factors and Alcohol Use Disorder

Inhibition of FGF Receptor-1 Suppresses Alcohol Consumption: Role of PI3 Kinase Signaling in Dorsomedial Striatum

Lyn kinase regulates mesolimbic dopamine release: implication for alcohol reward

Memory erasure, enhanced extinction and disrupted reconsolidation.

Positive autoregulation of GDNF levels in the ventral tegmental area mediates long-lasting inhibition of excessive alcohol consumption ⬇️

Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia.

Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat.

Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target

Re-exposure to nicotine-associated context from adolescence enhances alcohol intake in adulthood.

Recent Advances in the Discovery and Preclinical Testing of Novel Compounds for the Prevention and/or Treatment of Alcohol Use Disorders ⬇️

Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.

The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia.

The role of fibroblast growth factor 2 in drug addiction